Impact of menopause on the women's health

Article information

J Korean Med Assoc. 2019;62(3):141-144

Publication date (electronic) : 2019 March 19

doi : https://doi.org/10.5124/jkma.2019.62.3.141

Yong Jin Na, MD

Department of Obstetrics and Gynecology, Pusan National University College of Medicine, Busan, Korea.

Corresponding author: Yong Jin Na. yjna@pusan.ac.kr

Received 2019 March 05; Accepted 2019 March 11.

Abstract

Menopause is a consequence of loss of ovarian function. Withdrawal of estrogen level cause various menopausal symptoms. Change in the estrogen level can affect large areas of body target, causing atrophy of tissues and metabolic modifications with psychological and sexual changes that are variably experienced by individual woman. Short-term consequences of estrogen deprivation include vasomotor symptoms and urogenital atrophy. Long-term consequences of estrogen deprivation include cardiovascular disease, bone loss and osteoporosis, cognitive decline and Alzheimer's disease.

Keywords: Menopause; Estrogens; Women's health

References

1. Takahashi TA, Johnson KM. Menopause. Med Clin North Am 2015;99:521–534.

2. Kim HY, Park JC. Endocrinology of menopause. In : Kim JG, Choi H, eds. Gynecologic endocrinology Seoul: Kunja; 2012. p. 475–476.

3. Fritz MA, Speroff L. Menopause and the perimenopausal transition. In : Fritz MA, Speroff L, eds. Clinical gynecologic endocrinology and infertility 8th edth ed. Philadelphia: Lippincott Williams & Wilkins; 2011. p. 673–748.

4. Lobo RA. Menopause and aging. In : Strauss JF, Barbieri RL, eds. Yen & Jaffe's reproductive endocrinology 8th edth ed. Philadelphia: Elsevier; 2019. p. 322–356.

5. Nelson HD. Menopause. Lancet 2008;371:760–770.

6. Bernacchi G, Spina S, Cecchi E, Genazzani AR, Simoncini T. Menopause and HRT: doubts and certainties. In : Genazzani AR, Fauser BC, eds. Frontiers in gynecological endocrinology. Volume 2. From basic science to clinical application Heidelberg: Springer; 2015. p. 167–175.

7. Stenberg A, Heimer G, Ulmsten U, Cnattingius S. Prevalence of genitourinary and other climacteric symptoms in 61-year-old women. Maturitas 1996;24:31–36.

8. Brown JS, Vittinghoff E, Kanaya AM, Agarwal SK, Hulley S, Foxman B. Heart and Estrogen/Progestin Replacement Study Research Group. Progestin Replacement Study Research Group. Urinary tract infections in postmenopausal women: effect of hormone therapy and risk factors. Obstet Gynecol 2001;98:1045–1052.

9. Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 2000;10:509–515.

10. Brincat M, Moniz CF, Studd JW, Darby AJ, Magos A, Cooper D. Sex hormones and skin collagen content in post-menopausal women. Br Med J (Clin Res Ed) 1983;287:1337–1338.

11. Versi E, Cardozo L, Brincat M, Cooper D, Montgomery J, Studd J. Correlation of urethral physiology and skin collagen in postmenopausal women. Br J Obstet Gynaecol 1988;95:147–152.

12. Falconer C, Ekman-Ordeberg G, Ulmsten U, Westergren-Thorsson G, Barchan K, Malmstrom A. Changes in paraurethral connective tissue at menopause are counteracted by estrogen. Maturitas 1996;24:197–204.

13. Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 1976;85:447–452.

14. Byun DW, Yoon HG. 2018 Physician's guide for osteoporosis Seoul: CDM the Big Publishing Co; 2018.

15. MacLusky NJ, Naftolin F. Sexual differentiation of the central nervous system. Science 1981;211:1294–1302.

16. Henderson VW. Estrogen, cognition, and a woman's risk of Alzheimer's disease. Am J Med 1997;103:11S–18S.

Article information Continued

Korean Medical Association

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.